Stay updated on Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.

Latest updates to the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page
- Check5 days agoChange DetectedAdded related topics 'Schizophrenia' and MedlinePlus Genetics; removed the government funding/status notice.SummaryDifference0.1%

- Check12 days agoChange DetectedTwo new Local Institutions (Site 110 and Site 148) were added with their contact numbers, and recruitment-related entries and dates were updated.SummaryDifference0.3%

- Check19 days agoChange DetectedAdded related topics: Schizophrenia and MedlinePlus Genetics to the page.SummaryDifference0.2%

- Check26 days agoChange DetectedThe related topics 'Schizophrenia' and 'MedlinePlus Genetics' were removed from the study page. This reduces disease-specific tagging and can affect how the trial is discovered and indexed for schizophrenia-related searches.SummaryDifference0.0%

- Check34 days agoChange DetectedRemoved MedlinePlus Genetics topic: Schizophrenia, reducing coverage of genetics-related schizophrenia content.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Schizophrenia. This introduces genetic health information to the page but there are no deletions or other core changes.SummaryDifference0.1%

Stay in the know with updates to Extension Study for KarXT Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study for KarXT Safety in Schizophrenia Clinical Trial page.